News Center
Details
Renfu Puke Pharmaceutical’s Alfacalcidol Soft Capsules Selected for National Centralized Procurement
Release time:
2024-12-25 08:49
Source:
Recently, the National Healthcare Security Administration announced the results of the 10th round of nationally organized centralized bulk procurement of drugs, and Renfu Puke Pharmaceutical’s EdiCalciferol Soft Capsules were successfully selected.
Alfacalcidol soft capsules are a new-generation vitamin D derivative that, through a “dual mechanism” of promoting calcium absorption in the intestine and effectively inhibiting osteoblast differentiation, suppress bone resorption and enhance bone remodeling. They are currently widely used in the treatment of osteoporosis in postmenopausal women.
Centralized drug procurement helps reduce the financial burden of medication on patients and, to some extent, promotes transparency in drug quality and supply chains. In response to the national call to deepen reform of the medical and healthcare system, Renfu Puke Pharmaceutical actively participates in centralized drug procurement efforts and remains committed to pharmaceutical research and development and innovation, continuously introducing high-quality, high-performance drugs to meet the diverse needs of patients.
Trending News
Corporate culture
Make drug launches safer and faster, and ensure the tree of life remains evergreen.
Learn moreContact Us
Business customer service
-
Telephone：:+86-027-86506632
Human Resources Department
Address: No.98 shendun 2nd Road, Donghu New Technology Development Zone, Wuhan
Official wechat
Copyright: Wuhan humanwell likang pharmaceutical co.,ltd